Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beraprost + Aspirin for Arteriosclerosis in T2DM
NCT02786979Phase 4Terminated
- Sponsor
- Astellas Pharma
- Start
- Jul 2010
- Primary completion
- Jan 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of beraprost in arteriosclerosis (2 arms), sponsored by Astellas Pharma. Primary endpoint: Change from baseline in carotid intima-media thickness at 3 years. Started Jul 2010; status: terminated.
02
Drugs
beraprost
03
Conditions
arteriosclerosis
Beyond the preview
Go deeper on NCT02786979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02786979.